Outcomes of extra-dose exposures of Vaughan Williams Class I or III antidysrhythmic medications
Extra-dose exposures of some antidysrhythmics belonging to Vaughan Williams Class I or III were generally well tolerated, but more data are needed to determine whether certain patients can be safely monitored at home. For example, only three cases involved Class IA drugs. Based on our findings, patients who reportedly ingest an extra dose of an antidysrhythmic plus another cardioactive medication should be evaluated at a healthcare facility.
Authors
- Jeanna M. Marraffa (ORCID: https://orcid.org/0000-0001-9693-5123)
- Vince Calleo
- Ahmed Alsakha
- Michael Keenan
- Brenda Bukowiecki
Institutions
- Cleveland Clinic (US)
- SUNY Upstate Medical University (US)
- Abu Dhabi Health Services (AE)
- Upstate University Hospital (US)
- Washington Poison Center (US)
- Upstate Freshwater Institute (US)
- Atlantic Industries (Canada) (CA)
- Abu Dhabi Falcon Hospital (AE)
- Atlantic School of Theology (CA)
Publication Details
- Journal
- Clinical Toxicology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1080/15563650.2025.2581167
- Primary Topic
- Poisoning and overdose treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00